Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-17

Clinical Trial Update: The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic Hyperplasia [NA]

View source ↗

Summary

This clinical trial update investigates the effect of daily tamsulosin 0.2 mg on renal function in patients with benign prostatic hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamsulosin (tamsulosin)

Snippet

Sponsor: The Catholic University of Korea | Conditions: Chronic Kidney Failure, Prostatic Hyperplasia | NA | Status: UNKNOWN